悦康药业
(688658)
| 流通市值：72.41亿 | | | 总市值：72.41亿 |
| 流通股本：4.50亿 | | | 总股本：4.50亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,991,795,632.65 | 1,950,036,435.86 | 967,900,022.68 | 4,196,300,749.57 |
| 营业收入 | 2,991,795,632.65 | 1,950,036,435.86 | 967,900,022.68 | 4,196,300,749.57 |
| 二、营业总成本 | 2,730,072,277.72 | 1,804,764,081.76 | 904,066,984.17 | 3,960,329,636.78 |
| 营业成本 | 1,185,398,827.66 | 813,080,060.11 | 455,919,694.99 | 1,566,420,246.3 |
| 税金及附加 | 38,401,152.55 | 24,537,331.91 | 11,725,795.57 | 54,819,977.41 |
| 销售费用 | 1,077,257,545.89 | 679,465,232.64 | 294,028,028.72 | 1,767,160,867.82 |
| 管理费用 | 164,333,471.07 | 109,110,209.57 | 57,433,485.33 | 230,322,498.01 |
| 研发费用 | 261,146,138.06 | 177,628,128.64 | 85,499,658.32 | 351,879,003.83 |
| 财务费用 | 3,535,142.49 | 943,118.89 | -539,678.76 | -10,272,956.59 |
| 其中:利息费用 | 17,187,238.11 | 11,422,057.79 | 5,536,181.1 | 13,211,543 |
| 其中:利息收入 | 14,914,712.09 | 10,251,751.95 | 5,686,028.38 | 23,402,314.13 |
| 加:公允价值变动收益 | - | - | - | -686,875.22 |
| 加:投资收益 | - | - | - | -320,697.87 |
| 资产处置收益 | 29,443.79 | 205,252.61 | -606.84 | 1,043,142.4 |
| 资产减值损失(新) | -34,174,805.44 | -20,450,476.94 | 6,332,341.06 | -62,405,526.2 |
| 信用减值损失(新) | 4,478,983.3 | 7,118,137.28 | 3,420,596.9 | 13,726,834.35 |
| 其他收益 | 22,915,446.94 | 12,551,195.09 | 6,779,575.39 | 44,424,760.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 254,972,423.52 | 144,696,462.14 | 80,364,945.02 | 231,752,750.82 |
| 加:营业外收入 | 2,166,091.78 | 1,554,283.32 | 372,202.91 | 2,006,098.39 |
| 减:营业外支出 | 8,868,118.92 | 7,711,325.86 | 1,621,499.8 | 10,490,585.25 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 248,270,396.38 | 138,539,419.6 | 79,115,648.13 | 223,268,263.96 |
| 减:所得税费用 | 40,069,856.69 | 20,593,626.53 | 9,991,362.91 | 35,774,173.43 |
| 六、净利润 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 |
| 持续经营净利润 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 |
| 归属于母公司股东的净利润 | 209,725,063.28 | 118,553,513.19 | 69,305,423.83 | 184,795,719.38 |
| 少数股东损益 | -1,524,523.59 | -607,720.12 | -181,138.61 | 2,698,371.15 |
| (一)基本每股收益 | 0.47 | 0.26 | 0.15 | 0.41 |
| (二)稀释每股收益 | 0.47 | 0.26 | 0.15 | 0.41 |
| 九、综合收益总额 | 208,200,539.69 | 117,945,793.07 | 69,124,285.22 | 187,494,090.53 |
| 归属于母公司股东的综合收益总额 | 209,725,063.28 | 118,553,513.19 | 69,305,423.83 | 184,795,719.38 |
| 归属于少数股东的综合收益总额 | -1,524,523.59 | -607,720.12 | -181,138.61 | 2,698,371.15 |
| 公告日期 | 2024-10-31 | 2024-08-23 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |